11/14/2025 | Short News
Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, is joining the global community to mark World Diabetes Day on November 14, 2025. This year’s theme, “Diabetes and Well-being,” highlights the importance of supporti ## Article Body 11/14/2025 | Short News Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, is joining the global community to mark World Diabetes Day on November 14, 2025. This year’s theme, “Diabetes and Well-being,” highlights the importance of supporting the physical, mental, and emotional health of people living with diabetes and those at risk. As a trusted leader in kidney care, FME supports thousands of people affected by diabetes and kidney diseases every day. Diabetes is a common condition, affecting 1 in 9 adults worldwide, and up to 40% of people with diabetes will develop chronic kidney disease (CKD). Within our clinics, more than half of our dialysis patients are living with diabetes. Our teams are dedicated to providing education, personalized care, and a range of treatment options to help people manage their kidney health and well-being. In a special interview, Dr. Benjamin Hippen, Chief Medical Officer, Care Delivery at Fresenius Medical Care, discusses the global impact of diabetes, its connection to kidney health, and the importance of early detection. You can find the interview here. Throughout November, FME is sharing educational resources, personal stories, and expert insights to empower patients, caregivers, employees, and others. To learn more about these resources and activities, please click here. World Diabetes Day is the world's largest diabetes awareness campaign, reaching a global audience of over one billion people in 160 countries. With 589 million people worldwide affected by diabetes, there is a great need for holistic care, comprehensive support, and education. This Day of education and awareness is marked every year on November 14. Please find more info via this link: World Diabetes Day. Back To top: ## Recent Company News - 2026-07-29 07:00 EST — [Fresenius Medical Care announces BEACON-US, generating real-world evidence supporting high-volume hemodiafiltration for U.S. dialysis patients](https://biopharmsignal.com/news/FMS/fresenius-medical-care-announces-beacon-us-generating-real-world-evidence-suppor-8547f5f8) — Source: Fresenius Medical Care Ventures - 2026-07-20 07:00 EST — [Fresenius Medical Care introduces TherapyWise™ analytics for kidney replacement therapy](https://biopharmsignal.com/news/FMS/fresenius-medical-care-introduces-therapywise-analytics-for-kidney-replacement-t-6fa82f2a) — Source: Fresenius Medical Care Ventures - 2026-06-10 07:00 EST — [Interwell Health Delivers Strong Quality Scores and Shared Savings in CMS Value-Based Kidney Care Model](https://biopharmsignal.com/news/FMS/interwell-health-delivers-strong-quality-scores-and-shared-savings-in-cms-value--e2c55e86) — Source: Fresenius Medical Care Ventures - 2026-06-03 07:00 EST — [Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis](https://biopharmsignal.com/news/FMS/fresenius-medical-care-launches-kinexus-worldwide-a-unified-digital-platform-to-support-home-dialysis) — Source: Fresenius Medical Care Ventures - 2026-05-28 07:00 EST — [Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million](https://biopharmsignal.com/news/FMS/fresenius-medical-care-launches-first-tranche-of-its-share-buyback-program-of-up-to-eur-600-million) — Source: Fresenius Medical Care Ventures ## Related News - 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9) - 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627) - 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922) - 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c) - 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)